{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:12:10Z","timestamp":1790115130117,"version":"4.0.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide, and inflammatory bowel disease (IBD) comprises a group of chronic, relapsing inflammatory bowel disorders. Although IgAN and IBD differ in clinical manifestations, both involve interactions among genetic susceptibility, epigenetic abnormalities, and gut microbiota dysbiosis, ultimately pointing to mucosal immune dysregulation and chronic inflammation. They share similar alterations in gut microecology, characterized by a reduction in short-chain fatty acid-producing protective commensals and an increase in pathogenic symbionts. This leads to intestinal barrier disruption and aberrant microbial metabolites, promoting the production of galactose-deficient IgA1 (Gd-IgA1), activating intestinal mucosal immune cells, and driving both local and systemic inflammation. Notably, glucocorticoids (GC) and immunomodulators are common therapeutic agents for both diseases, and effective treatment is accompanied by restoration of the gut microbiota and improvement of immune imbalance. The four currently marketed budesonide enteric-coated capsules employ pH-dependent targeted-release technology and act on different sites ranging from the terminal ileum to the colon to modulate B-cell activation and attenuate local inflammation. IgAN and IBD may be closely related mucosal immune disorders, with immune inflammation associated with gut microbiota dysbiosis may represent a key link between them. Furthermore, upper respiratory tract infection may participate in the development of IgAN through mucosal immunity. The efficacy of tonsillectomy as a therapeutic intervention suggests the existence of crosstalk between the respiratory tract and the kidneys.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1889646","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:11:57Z","timestamp":1785312717000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbiota dysbiosis and immune responses: insights from IgA nephropathy and inflammatory bowel disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Lu","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, China"]},{"name":"Department of Nephrology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People\u2019s Hospital)","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaosi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1436923","article-title":"Contemporary review of IgA nephropathy","volume":"15","author":"Filippone","year":"2024","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2025.151564","article-title":"IgA nephropathy: Epidemiology and disease risk across the world","volume":"44","author":"Ghaddar","year":"2024","journal-title":"Semin Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/thno.104631","article-title":"The evolving understanding of systemic mechanisms in organ-specific IgA nephropathy: a focus on gut-kidney crosstalk","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00871-y","article-title":"The mucosal immune system and IgA nephropathy","volume":"43","author":"Gesualdo","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","article-title":"The pathogenesis of IgA nephropathy and implications for treatment","volume":"21","author":"Cheung","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00395-z","article-title":"Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives","volume":"7","author":"Yang","year":"2026","journal-title":"Mol BioMed"},{"key":"B8","doi-asserted-by":"publisher","first-page":"09287329251340770","DOI":"10.1177\/09287329251340770","article-title":"Infliximab may contribute to remit rapidly progressive of IgA nephropathy secondary to Crohn\u2019s disease: a case report","author":"Wan","year":"2025","journal-title":"Technol Health Care"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-068803","article-title":"Pediatric case of Crohn disease, immunoglobulin A nephropathy, and atopic dermatitis","volume":"155","author":"Sugino","year":"2025","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-025-01001-5","article-title":"A case of IgA nephropathy associated with Crohn\u2019s disease treated with enteric-coated budesonide","volume":"14","author":"Yoshida","year":"2025","journal-title":"CEN Case Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00419","article-title":"CARD9 signaling in intestinal immune homeostasis and oncogenesis","volume":"10","author":"Hartjes","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00005-023-00677-w","article-title":"Omics are getting us closer to understanding IgA nephropathy","volume":"71","author":"Mucha","year":"2023","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000530262","article-title":"Polymorphisms of CARD9 gene predict disease progression and renal survival of immunoglobulin A nephropathy","volume":"48","author":"He","year":"2023","journal-title":"Kidney Blood Press Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40168-024-01798-w","article-title":"Dissecting the respective roles of microbiota and host genetics in the susceptibility of Card9-\/- mice to colitis","volume":"12","author":"Danne","year":"2024","journal-title":"Microbiome"},{"key":"B17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.gastro.2013.05.047","article-title":"Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice","volume":"145","author":"Sokol","year":"2013","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nm.4102","article-title":"CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands","volume":"22","author":"Lamas","year":"2016","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010010076","article-title":"HLA has strongest association with IgA nephropathy in genome-wide analysis","volume":"21","author":"Feehally","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40291-023-00678-7","article-title":"The genetics of inflammatory bowel disease","volume":"28","author":"El Hadad","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-024-02642-9","article-title":"The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease","volume":"143","author":"O\u2019Brien","year":"2024","journal-title":"Hum Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002765","article-title":"Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis","volume":"8","author":"Kiryluk","year":"2012","journal-title":"PloS Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-104304","article-title":"Genome-wide association study identifies variants in HORMAD2 associated with tonsillectomy","volume":"54","author":"Feenstra","year":"2017","journal-title":"J Med Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.1038\/s41467-022-34456-6","article-title":"Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010096","article-title":"Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy","volume":"26","author":"Zhu","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017010019","article-title":"Deletion variants of CFHR1 and CFHR3 associate with mesangial immune deposits but not with progression of IgA nephropathy","volume":"29","author":"Jullien","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32415","article-title":"The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease","volume":"122","author":"Cuthbert","year":"2002","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac124","article-title":"NOD2 in Crohn\u2019s disease\u2014unfinished business","volume":"17","author":"Ashton","year":"2022","journal-title":"J Crohns Colitis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1093\/jimmun\/vkaf204","article-title":"Resolving the field: a role for Nod2 in T cells","volume":"214","author":"Huey","year":"2025","journal-title":"J Immunol Author Choice"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1433620","article-title":"NOD2-mediated dual negative regulation of inflammatory responses triggered by TLRs in the gastrointestinal tract","volume":"15","author":"Masaki","year":"2024","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011060567","article-title":"Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy","volume":"23","author":"Serino","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv032","article-title":"Role of let-7b in the regulation of N -acetylgalactosaminyltransferase 2 in IgA nephropathy","volume":"30","author":"Serino","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112305","article-title":"DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy","volume":"10","author":"Sun","year":"2015","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm781","article-title":"External suppression causes the low expression of the Cosmc gene in IgA nephropathy","volume":"23","author":"Qin","year":"2008","journal-title":"Nephrol Dialysis Transplant"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13507","article-title":"Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease","volume":"7","author":"Ventham","year":"2016","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160462","article-title":"Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome","volume":"214","author":"Neudecker","year":"2017","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"28011","DOI":"10.1038\/s41598-025-13629-5","article-title":"Reduced butyrate-producing bacteria and altered metabolic pathways in the gut microbiome of immunoglobulin A nephropathy patients","volume":"15","author":"Popova","year":"2025","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2399749","article-title":"Gut and respiratory microbiota landscapes in IgA nephropathy: a cross-sectional study","volume":"46","author":"Yuan","year":"2024","journal-title":"Ren Fail"},{"key":"B41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","article-title":"Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review","volume":"158","author":"Pittayanon","year":"2020","journal-title":"Gastroenterology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0451-9","article-title":"The influence of the microbiome on respiratory health","volume":"20","author":"Wypych","year":"2019","journal-title":"Nat Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90873-5","article-title":"Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency","volume":"90","author":"Ovesen","year":"1986","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12866-024-03235-2","article-title":"The effect of in vitro simulated colonic pH gradients on microbial activity and metabolite production using common prebiotics as substrates","volume":"24","author":"Xie","year":"2024","journal-title":"BMC Microbiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01092-6","article-title":"Intestinal pH: a major driver of human gut microbiota composition and metabolism","volume":"22","author":"Brinck","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13578-025-01385-y","article-title":"Distribution of gut microbiota across intestinal segments and their impact on human physiological and pathological processes","volume":"15","author":"Yang","year":"2025","journal-title":"Cell Biosci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.136.10.3631","article-title":"Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues","volume":"136","author":"Kett","year":"1986","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.904401","article-title":"Gut microbiome characteristics in IgA nephropathy: qualitative and quantitative analysis from observational studies","volume":"12","author":"Han","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.557368","article-title":"A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy","volume":"10","author":"Dong","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1061629","article-title":"Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease","volume":"12","author":"Hu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022020189","article-title":"Expansion of Escherichia-Shigella in gut is associated with the onset and response to immunosuppressive therapy of IgA nephropathy","volume":"33","author":"Zhao","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12882-020-01741-9","article-title":"Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study","volume":"21","author":"Hu","year":"2020","journal-title":"BMC Nephrol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae052","article-title":"IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway","volume":"39","author":"Zhu","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2025.100494","article-title":"Gut microbial metabolite, sphingosine-1-phosphate (S1P), drives mesangial cell phenotypic transformation and accelerates progression of IgA nephropathy via CCL2-MET-FAK pathway","volume":"9","author":"Tang","year":"2025","journal-title":"Curr Res Microb Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-025-03897-0","article-title":"Is the microbiome the answer to inflammatory bowel disease: systematic review","volume":"411","author":"Shah","year":"2025","journal-title":"Langenbecks Arch Surg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jare.2025.08.017","article-title":"Microbiome-metabolome generated bile acids gatekeep infliximab efficacy in Crohn\u2019s disease by licensing M1 suppression and Treg dominance","volume":"83","author":"Liu","year":"2026","journal-title":"J Adv Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1595884","article-title":"Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics","volume":"15","author":"Orejudo","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.09.056","article-title":"Inflammatory bowel diseases and the microbiome: searching the crime scene for clues","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-335331","article-title":"Adherent-invasive Escherichia coli in Crohn\u2019s disease: the 25th anniversary","volume":"75","author":"Barnich","year":"2026","journal-title":"Gut"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30504","article-title":"CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease","volume":"117","author":"Barnich","year":"2007","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.9.5529-5537.2001","article-title":"Adherent invasive Escherichia coli strains from patients with Crohn\u2019s disease survive and replicate within macrophages without inducing host cell death","volume":"69","author":"Glasser","year":"2001","journal-title":"Infect Immun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1780865","article-title":"Gut microbial metabolites in inflammatory bowel disease: immunological mechanisms regulating Treg\/Th17 balance and therapeutic potential","volume":"17","author":"Chen","year":"2026","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12882-021-02414-x","article-title":"Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy","volume":"22","author":"Chai","year":"2021","journal-title":"BMC Nephrol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.08.002","article-title":"ISN Forefronts Symposium 2015: IgA nephropathy, the gut microbiota, and gut-kidney crosstalk","volume":"1","author":"Han","year":"2016","journal-title":"Kidney Int Rep"},{"key":"B66","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1706472","article-title":"Gut microbiota metabolites in the immunoregulation of enteritis: research progress","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/MNH.0000000000000374","article-title":"Bile acid receptors and the kidney","volume":"27","author":"Herman-Edelstein","year":"2018","journal-title":"Curr Opin Nephrol Hypertension"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010021","article-title":"Protein-bound uremic toxins induce tissue remodeling by targeting the EGF receptor","volume":"26","author":"Sun","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1488264","article-title":"The microbial metabolite trimethylamine N-oxide and the kidney diseases","volume":"15","author":"Su","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2025.04.004","article-title":"KDIGO 2025 clinical practice guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV)","volume":"108","author":"Rovin","year":"2025","journal-title":"Kidney Int"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1159\/000487903","article-title":"Glucocorticoids reduce aberrant O-glycosylation of IgA1 in IgA nephropathy patients","volume":"43","author":"Kosztyu","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000816","article-title":"Role of systemic glucocorticoids in reducing IgA and galactose-deficient IgA1 levels in IgA nephropathy","volume":"20","author":"Zan","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2021.1936038","article-title":"Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports","volume":"43","author":"Zhao","year":"2021","journal-title":"Ren Fail"},{"key":"B75","doi-asserted-by":"publisher","first-page":"22935","DOI":"10.1038\/s41598-024-74171-4","article-title":"Safety and efficacy assessment of fecal microbiota transplantation as an adjunctive treatment for IgA nephropathy: an exploratory clinical trial","volume":"14","author":"Zhi","year":"2024","journal-title":"Sci Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2458184","article-title":"Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"B77","unstructured":"British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01894-24","article-title":"The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab","volume":"13","author":"Ventin-Holmberg","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1651063","article-title":"Th17\/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation","volume":"16","author":"Hu","year":"2025","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21271","article-title":"Peripheral regulatory T cells and serum transforming growth factor-\u03b2: relationship with clinical response to infliximab in Crohn\u2019s disease","volume":"16","author":"Di Sabatino","year":"2010","journal-title":"Inflammatory Bowel Dis"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318280292b","article-title":"Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy","volume":"19","author":"Caprioli","year":"2013","journal-title":"Inflammatory Bowel Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01554-4","article-title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial","volume":"402","author":"Lafayette","year":"2023","journal-title":"Lancet"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000583","article-title":"Efficacy and safety of Nefecon in patients with IgA nephropathy from Mainland China: 2-year NefIgArd trial results","volume":"5","author":"Zhang","year":"2024","journal-title":"Kidney360"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S383138","article-title":"Insights on Nefecon\u00ae, a targeted-release formulation of budesonide and its selective immunomodulatory effects in patients with IgA nephropathy","volume":"18","author":"Barratt","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.11.003","article-title":"Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial","volume":"105","author":"Wimbury","year":"2024","journal-title":"Kidney Int"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3109\/00365513.2011.652158","article-title":"Imbalance of regulatory T cells to Th17 cells in IgA nephropathy","volume":"72","author":"Lin","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"B87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10157-018-1665-0","article-title":"T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target","volume":"23","author":"Ruszkowski","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2023.1346769","article-title":"The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies","volume":"3","author":"Cheung","year":"2024","journal-title":"Front Nephrol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12882-025-04689-w","article-title":"Efficacy and safety of BAFF\/APRIL dual antagonists in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Tian","year":"2025","journal-title":"BMC Nephrol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016050496","article-title":"Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cells in IgA nephropathy","volume":"28","author":"Muto","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1737992","article-title":"Aberrant signaling in tonsillar B cells producing pathogenic O-glycoforms of IgA1 in IgA nephropathy","volume":"17","author":"Yamada","year":"2026","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2016.04.008","article-title":"Thymic stromal lymphopoietin in tonsillar follicular dendritic cells correlates with elevated serum immunoglobulin A titer by promoting tonsillar immunoglobulin A class switching in immunoglobulin A nephropathy","volume":"176","author":"Meng","year":"2016","journal-title":"Trans Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.11.003","article-title":"LIF\/JAK2\/STAT1 signaling enhances production of galactose-deficient IgA1 by IgA1-producing cell lines derived from tonsils of patients with IgA nephropathy","volume":"9","author":"Yamada","year":"2023","journal-title":"Kidney Int Rep"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq674","article-title":"A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy","volume":"26","author":"Wang","year":"2011","journal-title":"Nephrol Dialysis Transplant"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf262","article-title":"Tonsillectomy and immunosuppression improve outcomes in Caucasians with high-risk IgA nephropathy","volume":"41","author":"Kochoyan","year":"2026","journal-title":"Nephrol Dialysis Transplant"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000457","article-title":"Association of inflammatory bowel disease with incident IgA nephropathy","volume":"19","author":"Nakayama","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.12.026","article-title":"Multi-omics analyses reveal the pathogenic role of terminal ileum-derived IgA+\u03b27+ cells in IgA nephropathy","volume":"109","author":"Liu","year":"2026","journal-title":"Kidney Int"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1059692","article-title":"Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes","volume":"12","author":"Dong","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2514184","article-title":"Gut microbiota as a predictive tool for outcomes in IgA nephropathy","volume":"47","author":"Dong","year":"2025","journal-title":"Ren Fail"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/genes13122388","article-title":"Genetic and epigenetic etiology of inflammatory bowel disease: An update","volume":"13","author":"Jarmakiewicz-Czaja","year":"2022","journal-title":"Genes (Basel)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000083","article-title":"Identification of epigenetic methylation signatures with clinical value in Crohn\u2019s disease","volume":"10","author":"Moret-Tatay","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13081941","article-title":"Predictive microbial markers distinguish responders and non-responders to adalimumab: A step toward precision medicine in ulcerative colitis","volume":"13","author":"Ghavami","year":"2025","journal-title":"Microorganisms"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13195794","article-title":"Alterations of the gut microbiome and TMAO levels in patients with ulcerative colitis","volume":"13","author":"Laryushina","year":"2024","journal-title":"J Clin Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1438683","article-title":"Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy","volume":"16","author":"Yao","year":"2025","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.01.014","article-title":"Treatment of patients with IgA nephropathy: A call for a new paradigm","volume":"107","author":"Floege","year":"2025","journal-title":"Kidney Int"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1889646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:11:59Z","timestamp":1785312719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1889646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2026.1889646"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1889646","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1889646"}}